Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2907269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Xinxing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China. Hauptthemen laut MEDLINE: Gemcitabine, Deoxycytidine, Drug Resistance, Neoplasm, Pancreatic Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province, Foundation research project of Qinghai province.
Abstract (Originalsprache)
Background
The TGF-β gene is a gemcitabine (GEM) resistance gene; however, the mechanism by which it regulates GEM resistance in pancreatic cancer remains unclear.
Methods
The PANC-1 cell line was treated with GEM and then stimulated with TGF-β. Subsequently, we constructed GEM-resistant pancreatic cancer cell lines, knocked down TGF-β in these cell lines, and detected changes in the proliferation and apoptosis of drug-resistant cancer cells. In addition, the protein expression levels of KLF-4, GFI-1, and ZEB-1 were determined. The xenograft tumor models of nude mice were constructed by subcutaneously injecting GEM-resistant PANC-1 cells into mouse axilla. The tumors were removed, dissected, and weighed after 6 weeks. The protein levels of KLF-4, GFI-1, and ZEB-1 in tumor tissues were quantified. In addition, the percentage of M2 macrophages in tumor tissues was determined using flow cytometry.
Results
The protein levels of TGF-β in pancreatic cancer cells were significantly decreased after GEM treatment. The protein expression of KLF-4 was downregulated, whereas the expressions of GFI-1 and ZEB-1 were upregulated after TGF-β stimulation. Apoptosis increased and proliferation decreased after TGF-β knockdown in GEM-resistant pancreatic cancer cells, moreover, silencing TGF-β promoted the expression of Caspase 3 and Cleaved caspase 3. In addition, the protein expression of KLF-4 was upregulated, whereas the expressions of GFI-1 and ZEB-1 were downregulated. Further, the volume and weight of the transplanted tumor decreased after TGF-β knockdown. The protein expression of KLF-4 was upregulated, whereas the expressions of GFI-1 and ZEB-1 were downregulated in tumor tissues. In addition, the percentage of M2 macrophages decreased in tumor tissues after TGF-β knockdown.
Conclusions
The knockdown of TGF-β inhibits epithelial-to-mesenchymal transition, suppresses the proliferation and promotes the apoptosis of drug-resistant cancer cells, and decreases the macrophage polarization to the M2 phenotype, consequently ameliorating GEM resistance in pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021 Jinan, Shandong, China.
- Liver Gall Bladder and Pancreatic Surgery Ward, Qinghai Red Cross Hospital, 810001 Xining, Qinghai, China.
Förderung
- Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province
- Foundation research project of Qinghai province
Zitieren
APA
Wang, X., Su, W., Qin, C., Gao, R., Shao, S., Xu, X., Zhang, Z., & Gao, J. (2024). Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907269
Vancouver
Wang X, Su W, Qin C, Gao R, Shao S, Xu X, et al. Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907269
BibTeX
@article{Wang2024,
author = {Wang, Xinxing and Su, Wei and Qin, Chuan and Gao, Ruxin and Shao, Shuai and Xu, Xianwen and Zhang, Zhenhai and Gao, Junlin},
title = {Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2907269}
}
EUVIMED